Elicit · Accuracy
Elicit Reaches 95–99% Accuracy on Systematic Literature Reviews
Six months ago 80–85% was the AI screening ceiling. Elicit has now crossed the bar for clinical trial systematic reviews, with FDA workflow conversations likely next.
AI Screening Crosses the Clinical Trial Bar
Six months ago 80–85% accuracy was considered the ceiling for AI-assisted literature screening.
PRISMA 2020-compliant and auditable; 95% search recall, 99% full-text screening, 96% extraction on 994 Cochrane reviews. For the first time, the accuracy threshold required for clinical trial systematic reviews has been cleared by an AI tool.
The Accuracy Numbers
Which Organizations Should Move Now
Pharma R&D: pilot in clinical protocol evidence review
PRISMA 2020 compliance aligns with regulatory submission formats. Elicit can now be considered for evidence structuring in FDA-bound documentation.
Universities: automate first-pass screening for guideline-compliant reviews
Route initial screening through Elicit, then confirm manually. The switch can cut weekly effort significantly on literature-heavy research projects.
Evidence synthesis outsourcers: model the cost of insourcing
At 95–99% accuracy, outsourced literature screening becomes a candidate for bringing in-house. Run a cost model before the next contract renewal.